Lipella Pharmaceuticals Inc. Common Stock (LIPO) stock news · rev $536.4K
Lipella Pharmaceuticals Inc. Common Stock (LIPO) is a biotechnology company listed on NASDAQ.
This LIPO news page leads with what Lipella Pharmaceuticals Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for LIPO yet. We will not pad this page with generic market recap.
Latest reported LIPO revenue for 2024-12-31 was $536.4K. Net income was -$5.0M. Revenue was up 19.3% from 2023-12-31 to 2024-12-31. LIPO currently screens at market cap $254.1K.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LIPO stock page; for the tape open the quote page.
Not investment advice.